Laurence Lanfumey facts for kids
Quick facts for kids
Laurence Lanfumey-Mongredien
|
|
---|---|
Born | 7 November 1954 |
Education | PhD in Neurophysiology, University of Paris VI (Pierre-and-Marie-Curie University)(1981) |
Known for | Pathophysiology of mood disorders |
Awards | CINP, Prix Georges de Saint-Blanquat |
Scientific career | |
Fields | Neuroscience |
Institutions | Centre de Psychiatrie et Neurosciences (CPN) INSERM U894 |
Laurence Lanfumey-Mongredien is a scientist who studies the brain and how medicines affect it. She is a neuroscientist. She works at INSERM, a big research center in France. She leads a team that studies brain problems like depression, anxiety, and addiction.
She is also part of many science groups. For example, she was a leader in the European College of Neuropsychopharmacology.
Contents
Her Career in Science
Learning and Studying
Laurence Lanfumey-Mongredien earned her PhD (a high-level science degree) in Neurophysiology. She got this degree from Pierre and Marie Curie University in Paris.
She did research at famous universities like Princeton and Yale in the United States. Today, she is a Director of Research at INSERM in Paris. She works at the Research Centre of Psychiatry and Neuroscience.
What She Studies
Laurence Lanfumey-Mongredien leads a research group. This group studies the causes of anxiety, depression, and addiction. Their goal is to understand how our genes and the world around us affect these brain conditions. They also look at how these conditions can be treated.
Awards and Recognition
Laurence Lanfumey-Mongredien has won several awards for her work:
- 1994: Collegium International NeuroPsychoPharmacologicum (CINP)
- 2002: Merck Sharp and Dohme Medical School Grant (UK)
- 2013: Prix Georges de Saint-Blanquat (Ireb, France)
Helping Other Scientists
Laurence Lanfumey-Mongredien helps other scientists by being on the editorial boards of many science journals. These journals include Neurochemical Research and Neuroscience. She also belongs to different science groups, like the Society for Neurosciences. From 2013 to 2019, she was part of the main committee for the European College of Neuropsychopharmacology.